Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Personalis' Sequencing and Interpretation Services; GnuBio to Ship Beta System

Premium

Personalis has launched services for genomic sequencing and interpretation, including its ACE Exome and ACE Genome sequencing services, which supplement standard exome and whole-genome sequencing with additional targeted sequencing to improve accuracy and coverage of medically interpretable regions.

The company also offers standard exome and whole-genome sequencing using Illumina's TruSeq enrichment chemistry and sequencing on the HiSeq 2000 or HiSeq 2500.


GnuBio said it will begin shipping beta versions of its desktop sequencing system in April. The company's system is based on microfluidic sequencing technology and will have a list price of $50,000 (IS 9/11/2012).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.